NCT02218554View on ClinicalTrials.gov

Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay

NAUnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Bisphosphonate-related Osteonecrosis of the Jaw
Interventions
GENETIC

BRONJ

collection of the blood sample from the subject for evaluation of the Micromedic BRONJ Risk Assessment in vitro Diagnostic Assay

Trial Locations (2)

Unknown

RECRUITING

Sheba Medical Center, Tel Litwinsky

RECRUITING

Sheba Medical Center, Tel Litwinsky

Sponsors
All Listed Sponsors
lead

Micromedic Technologies Ltd

INDUSTRY